Anika Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANIK research report →
Companywww.anikatherapeutics.com
Anika Therapeutics, Inc. , a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform.
- CEO
- Stephen D. Griffin
- IPO
- 1993
- Employees
- 288
- HQ
- Bedford, MA, US
Price Chart
Valuation
- Market Cap
- $201.07M
- P/E
- -18.48
- P/S
- 1.73
- P/B
- 1.53
- EV/EBITDA
- -28.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 58.59%
- Op Margin
- -10.54%
- Net Margin
- -9.52%
- ROE
- -7.74%
- ROIC
- -7.64%
Growth & Income
- Revenue
- $112.82M · -5.91%
- Net Income
- $-10,880,000 · 80.70%
- EPS
- $-0.76 · 80.16%
- Op Income
- $-11,051,000
- FCF YoY
- 287.13%
Performance & Tape
- 52W High
- $16.24
- 52W Low
- $7.87
- 50D MA
- $14.76
- 200D MA
- $10.99
- Beta
- 0.16
- Avg Volume
- 133.53K
Get TickerSpark's AI analysis on ANIK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | HENNEMAN JOHN B III | buy | 5,000 |
| Apr 30, 26 | Griffin Stephen D. | buy | 12,200 |
| Mar 19, 26 | McLeod Ian | other | 17,663 |
| Mar 19, 26 | McLeod Ian | other | 13,097 |
| Mar 19, 26 | McLeod Ian | other | 11,194 |
| Mar 15, 26 | Colleran David | other | 6,449 |
| Mar 15, 26 | Colleran David | other | 1,893 |
| Mar 14, 26 | Colleran David | other | 4,694 |
| Mar 14, 26 | Colleran David | other | 4,168 |
| Mar 14, 26 | Colleran David | other | 9,388 |
Our ANIK Coverage
We haven't published any research on ANIK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ANIK Report →